Fairman Group’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-10
Closed -$10.5K 409
2024
Q2
$10.5K Hold
10
0.01% 167
2024
Q1
$9.63K Hold
10
0.01% 161
2023
Q4
$8.78K Buy
+10
New +$8.78K 0.01% 164